You are here: Home > HCP > ASCI > ASCI therapeutic settings

Patient website

Website dedicated to help patients, their family and friends about the cancer immunotherapeutic approach in an easy-to-understand format.

Visit Patient website

MAGRIT trial

Website providing information about the now recruiting Non-Small Cell Lung Cancer phase III clinical study

www.ascitrials.com

This section describes the two ASCI potential therapeutic settings:

Adjuvant setting to reduce the risk of tumor recurrence following surgery.
Metastatic setting to prevent progression in patients with low metastatic burden.

Login

If this is your first time at this site, please click here to register.

For legal reasons, this page is intended solely for healthcare professionals. This is why we ask you to register.

Last update: 27-May-2009

ASCIs are investigational compounds